
### [NCIT:C9450](http://purl.obolibrary.org/obo/NCIT_C9450)
**Label:** Grade 2 Rectal Adenocarcinoma

**Subclasses:** 

**Class expressions from DL-Learner:**

- Thing 54.93%
- [NCIT:C28078](http://purl.obolibrary.org/obo/NCIT_C28078) (Grade 2) 51.32%
- [NCIT:C25785](http://purl.obolibrary.org/obo/NCIT_C25785) (KRAS Gene) 51.32%
- [NCIT:C18363](http://purl.obolibrary.org/obo/NCIT_C18363) (BRAF Gene) 51.32%
- [NCIT:C17567](http://purl.obolibrary.org/obo/NCIT_C17567) (APC Gene) 51.32%
- [NCIT:C17359](http://purl.obolibrary.org/obo/NCIT_C17359) (TP53 Gene) 51.32%
- [NCIT:C25784](http://purl.obolibrary.org/obo/NCIT_C25784) (RAS Family Gene) and (not ([NCIT:C25786](http://purl.obolibrary.org/obo/NCIT_C25786) (NRAS Gene))) 36.67%
- [NCIT:C25784](http://purl.obolibrary.org/obo/NCIT_C25784) (RAS Family Gene) and (not ([NCIT:C17060](http://purl.obolibrary.org/obo/NCIT_C17060) (HRAS Gene))) 36.67%
- [NCIT:C25784](http://purl.obolibrary.org/obo/NCIT_C25784) (RAS Family Gene) 30.18%
- [NCIT:C18437](http://purl.obolibrary.org/obo/NCIT_C18437) (G Protein Gene) 30.18%
- [NCIT:C25784](http://purl.obolibrary.org/obo/NCIT_C25784) (RAS Family Gene) and (not ([NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma))) 30.18%
- [NCIT:C25784](http://purl.obolibrary.org/obo/NCIT_C25784) (RAS Family Gene) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 30.18%
- [NCIT:C25784](http://purl.obolibrary.org/obo/NCIT_C25784) (RAS Family Gene) and (not ([NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma))) 30.18%
- [NCIT:C25784](http://purl.obolibrary.org/obo/NCIT_C25784) (RAS Family Gene) and (not ([NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma))) 30.18%
- [NCIT:C25784](http://purl.obolibrary.org/obo/NCIT_C25784) (RAS Family Gene) and (not ([NCIT:C40148](http://purl.obolibrary.org/obo/NCIT_C40148) (Grade 3 Endometrial Endometrioid Adenocarcinoma))) 30.18%


